Psychiatric symptoms associated with ephedra use

Area of Science:

• Pharmacovigilance
• Psychiatry
• Herbal Medicine Safety

Background:

• Dietary supplements containing ephedra have been associated with various adverse events.
• Understanding the psychiatric risks of ephedra use is crucial for public health.
• Previous reports suggest potential neurological and psychological effects.

Purpose of the Study:

• To document psychiatric adverse events following ephedra-containing dietary supplement ingestion.
• To evaluate the potential relationship between ephedra use and these psychiatric events.
• To analyze serious psychiatric complications reported in the US FDA MedWatch database.

Main Methods:

• Review of US FDA MedWatch adverse event reports concerning herbal ephedra dietary supplements up to September 30, 2001.
• Classification of psychiatric events, including psychosis, mania, severe depression, hallucinations, delusions, suicide attempts, paranoia, and violent behavior.
• Categorization of events based on the strength of evidence supporting a causal relationship.

Main Results:

• Out of nearly 1800 total adverse events, 57 were identified as serious and psychiatric.
• Two-thirds of these psychiatric cases involved individuals with pre-existing mental health conditions or concurrent use of other substances.
• The majority of case reports lacked sufficient documentation to establish a definitive causal link.

Conclusions:

• The reviewed case reports do not conclusively prove a causal relationship between ephedra and psychiatric complications.
• However, the findings raise concerns about a potential association between ephedra use and serious psychiatric adverse events.
• Further research is needed to clarify the risks associated with ephedra-containing supplements.